Elevance Health Inc.
ELVLast close · Oct 16, 2026428.26−0.17 (−0.04%)
Market cap$92.9B
Of the 85 managers this site tracks, 12 held Elevance Health (ELV) at the end of Q2 2026, their latest 13Fs. The largest position by value was Bill Nygren's, $1.9B; First Eagle's ($1.6B) and Klarman's ($493.1M) follow. No Schedule 13D or 13G is on file for ELV from the activists and large holders the site follows.
Superinvestors holding ELV
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Bill Nygren | Harris Associates L P | Q2 2026 | 5M | $1.9B |
| First Eagle | First Eagle Investment Management, LLC | Q2 2026 | 4M | $1.6B |
| Klarman | Baupost Group LLC | Q2 2026 | 1M | $493.1M |
| Ruane Cunniff | Ruane, Cunniff & Goldfarb L.P. | Q2 2026 | 979,598 | $378.8M |
| Glenn Greenberg | Brave Warrior Advisors, LLC | Q2 2026 | 976,885 | $377.8M |
| Yacktman | Yacktman Asset Management LP | Q2 2026 | 339,985 | $131.5M |
| Harry Burn | Sound Shore Management Inc | Q2 2026 | 243,452 | $94.2M |
| Richard Pzena | Pzena Investment Management LLC | Q2 2026 | 224,575 | $86.8M |
| Vulcan Value | Vulcan Value Partners, LLC | Q2 2026 | 155,873 | $60.3M |
| Arnold Van Den Berg | Van Den Berg Management I, Inc | Q2 2026 | 27,514 | $10.6M |
| Tweedy Browne | Tweedy, Browne Co LLC | Q2 2026 | 6,417 | $2.5M |
| Dodge & Cox | Dodge & Cox | Q2 2026 | 1,300 | $502,749 |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.